George Yancopoulos
President and Chief Scientific at Regeneron Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Regeneron Pharmaceuticals Inc.
Director · Bd. Co-Chair, President & CSO
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2024 | Regeneron Pharmaceuticals Inc. | Gift | −75,799 | — | — |
| Jun 10, 2024 | Regeneron Pharmaceuticals Inc. | Gift | +37,900 | — | — |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −907 | $967.40 | $877,432 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3,213 | $968.44 | $3,111,598 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9,501 | $969.39 | $9,210,174 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4,669 | $970.26 | $4,530,144 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4,922 | $971.56 | $4,782,018 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −790 | $972.22 | $768,054 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −2,653 | $973.80 | $2,583,491 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −7,611 | $974.51 | $7,416,996 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9,242 | $975.48 | $9,015,386 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4,886 | $976.52 | $4,771,277 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1,227 | $977.38 | $1,199,245 |
| May 16, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −379 | $978.18 | $370,730 |
| May 15, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −111 | $965.69 | $107,192 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.